Editors: Unax Lertxundi, Juan Medrano, Rafael Hernández

Psychopharmacological Issues in Geriatrics

eBook: US $59 Special Offer (PDF + Printed Copy): US $148
Printed Copy: US $119
Library License: US $236
ISBN: 978-1-68108-035-2 (Print)
ISBN: 978-1-68108-034-5 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810803451150101

Introduction

Demographic changes due to improved life expectancy and access to medical care has increased the number of people aged 65 years and beyond. This raises an important new challenge for healthcare professionals. Changes in organ functions, homeostatic mechanisms and receptor responsiveness impair drug distribution, metabolism and excretion, and reduce the effectiveness of medicines among geriatric patients. As a consequence, management of medical regimens is much more challenging in the elderly than in younger adult patients. Elderly patients are also more susceptible than other age groups to certain drug-drug interactions, drug-disease interactions and adverse drug reactions owing to the number of drugs administered.

Polypharmacy and potentially inappropriate medication is a common finding in the elderly healthcare and it is considered a public health issue related to morbidity, mortality and health care resource use.

Psychopharmacological Issues in Geriatrics can be regarded as a ‘pharmacovigilance’ manual for elderly patients as it presents recommendations for geriatric prescription with specific considerations.

The book also provides a comprehensive review of specific classes of psychopharmacological agents used to treat geriatric patients, including antipsychotics, anxiolytics, hypnotics and mood stabilizers. The book is intended as a handbook for general medical and nursing practitioners.

Foreword

- Pp. i-ii (2)
Enrique Echevarria
Download Free

Preface

- Pp. iii-v (3)
Unax Lertxundi, Juan Medrano, Rafael Hernández
Download Free

List of Contributors

- Pp. vii
Unax Lertxundi, Juan Medrano, Rafael Hernández
Download Free

Historical Perspective of Psychotropic Drug Use

- Pp. 3-15 (13)
Juan Medrano
View Abstract

Evolution of Psychotropic Drug Use in Elderly Patients: Pharmaceuticals Emerging as Environmental Contaminants

- Pp. 17-30 (14)
Unax Lertxundi, Beatriz Corcostegui
View Abstract

Age-Related Pharmacokinetic/Pharmacodynamic Changes in Psychopharmacological Drugs

- Pp. 31-48 (18)
Arantxa Isla Ruiz, María Ángeles Solinís Aspiazu, Alicia Rodríguez- Gascón
View Abstract

Clinically Relevant Psychopharmacological Interactions in the Elderly

- Pp. 49-64 (16)
Ainhoa Urrutia, Javier Peral, Jesús Ángel Padierna
View Abstract

Potentially Inappropriate Medication in Elderly

- Pp. 65-109 (45)
Rafael Hernández, Ane Gómez de Segura, Juan Medrano, Beatriz Corcóstegui, Unax Lertxundi
View Abstract

Pharmacovigilance in Geropsychiatry

- Pp. 111-132 (22)
Carmelo Aguirre, Montserrat García
View Abstract

Anxiolytics and Hypnotics

- Pp. 133-153 (21)
Juan Medrano
View Abstract

Mood Stabilizers

- Pp. 155-185 (31)
Juan Medrano
View Abstract

Antidepressants

- Pp. 187-216 (30)
Juan Medrano
View Abstract

Antipsychotics

- Pp. 217-240 (24)
Juan Medrano
View Abstract

Antipsychotics in Dementia

- Pp. 241-271 (31)
Juan Medrano
View Abstract

Antipsychotic Use in Parkinson`s Disease

- Pp. 273-286 (14)
Saioa Domingo-Echaburu
View Abstract

Antipsychotic Polypharmacy in Elderly Patients

- Pp. 287-304 (18)
Amaia Lopez de Torre
View Abstract

Drugs Used in Substance Use Disorders

- Pp. 305-324 (20)
Juan Medrano
View Abstract

Drugs Used in the Treatment of Dementia and Neurocognitive Disorders

- Pp. 325-332 (8)
Juan Medrano
View Abstract

Subject Index

- Pp. 333-336 (4)
Unax Lertxundi, Juan Medrano, Rafael Hernández
Download Free

RELATED BOOKS

.Depression: A Silent Culprit in Health and Disease.
.How to Help the Suicidal Person to Choose Life: The Ethic of Care and Empathy as an Indispensable Tool for Intervention.
.Information for Mental Health Providers Working with Children who have Chronic Illnesses.
.Disease Prediction using Machine Learning, Deep Learning and Data Analytics.
.Exploration of Artificial Intelligence and Blockchain Technology in Smart and Secure Healthcare.
.Blockchain and IoT based Smart Healthcare Systems.
.Occupational Health and Safety.